Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Other Accumulated Expenses (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Other Accumulated Expenses for 16 consecutive years, with $14.9 million as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses rose 1104.29% to $14.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.9 million through Dec 2025, up 1104.29% year-over-year, with the annual reading at $14.9 million for FY2025, 1104.29% up from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $14.9 million at Harvard Bioscience, up from $1.6 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $14.9 million in Q4 2025, with the low at $956000.0 in Q3 2022.
  • Average Other Accumulated Expenses over 5 years is $3.7 million, with a median of $1.6 million recorded in 2024.
  • The sharpest move saw Other Accumulated Expenses tumbled 90.88% in 2022, then soared 1104.29% in 2025.
  • Over 5 years, Other Accumulated Expenses stood at $10.8 million in 2021, then crashed by 90.88% to $982000.0 in 2022, then increased by 26.27% to $1.2 million in 2023, then decreased by 0.48% to $1.2 million in 2024, then skyrocketed by 1104.29% to $14.9 million in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $14.9 million, $1.6 million, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.